DrYue Wang
CLIN AST PROF
MD-NEUROLOGY
GRANTS
- GRANTA Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related EpilepsyMarinus Pharmaceuticals26 Sep 2023 - 25 Apr 2024
- GRANTCTOA Wang - ResidualsUniversity of Florida27 Apr 2023 - 2 Jul 2026
- GRANTA Phase 3, Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related Epilepsy (TrustTSC)Marinus Pharmaceuticals17 Mar 2023 - 24 Jan 2025